To all Oklahoma patients and perhaps others across the nation:

To all Oklahoma patients and perhaps others across the nation:

If your doctor or nurse sees any type of unsafe practices, you would want them to report it for your safety. Right?
Now, last year, in order to address concerns about safety in the chain pharmacies and the lack of staff which caused delays in prescriptions and errors,
Oklahoma board of pharmacy put together a form which Pharmacists could fill to report lack of personnel.

Today, we have discovered and confirmed that CVS Pharmacy is requiring their pharmacists to let them know before they fill that particular form and report unsafe conditions to Oklahoma board of pharmacy.

Now to put that into perspective. Chain Pharmacists have already been afraid to speak up for their patients and themselves because their employers have found tactics to retaliate and intimidate them.
By CVS Health asking this of their pharmacists, the company is indirectly pushing their pharmacists to remain silent on the detrimental working conditions in the pharmacy.
As a patient and for the sake of your family, you should be concerned about this.
This is a tactic to intimidate pharmacists who are trying to be your advocate. This is a tactic to burry their voices.
Please know that Pharmacists are trying to be out there and to protect you! Please spread the word around the issues you are experiencing. Let your lawmakers know! Get in touch with our board of pharmacy.
Those companies are abusing their power with no fear of being held accountable for the harm they are causing!
Start to advocate for yourself and your loved ones.

 

FED LAW: those who are violating it – is the same who are suppose to enforce it ?

42 U.S. Code § 1395 – Prohibition against any Federal interference

https://www.law.cornell.edu/uscode/text/42/1395

Nothing in this subchapter shall be construed to authorize any Federal officer or employee to exercise any supervision or control over the practice of medicine or the manner in which medical services are provided, or over the selection, tenure, or compensation of any officer or employee of any institution, agency, or person providing health services; or to exercise any supervision or control over the administration or operation of any such institution, agency, or person.

(Aug. 14, 1935, ch. 531, title XVIII, § 1801, as added Pub. L. 89–97, title I, § 102(a), July 30, 1965, 79 Stat. 291.)

federal mask mandate on public transportation: exceeds the authority of President Biden’s Centers for Disease Control and Prevention

More than 20 states sue CDC over federal mask mandate on public transportation

https://www.abc15.com/news/national/coronavirus/more-than-20-states-sue-cdc-over-federal-mask-mandate-on-public-transportation

TALLAHASSEE, Fla. — 20 states are joining the state of Florida in a lawsuit against the federal mask mandate on public transportation.

Attorney General Ashley Moody and Governor Ron DeSantis announced the lawsuit on Tuesday.

In a press release, Moody’s office called the mandate “unlawful” and said it “exceeds the authority of President Biden’s Centers for Disease Control and Prevention.”

The other states included in the suit are Alabama, Alaska, Arizona, Arkansas, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Montana, Nebraska, Ohio, Oklahoma, South Carolina, Utah, Virginia and West Virginia.

In several instances, the lawsuit calls the mask mandate “arbitrary and capricious.”

Florida leaders claim there is no “high-quality data to support the efficacy of mask mandates, case numbers and hospitalizations experiencing a large downward trend, and 81.7% of the population having received at least one dose of the COVID-19 vaccine.”

The lawsuit doesn’t just call for an end to the mandate and a permanent injunction against enforcement, it also calls for the defendants to pay for attorney fees and other costs.

 

 

ACLU PA : sues over state courts prohibited/limited meds for OUD – VIOLATION OF ADA

How many pts have contacted the ACLU in their state about chronic pain pts being civil rights discriminated by the CDC prohibiting/limiting being prescribed medication to treat their chronic pain  and be told that the ACLU did not have the resources to deal with that issue ?

Department of Justice Finds PA Court System Violated Federal Law By Banning Medication for Opioid Use Disorder

https://www.aclupa.org/en/press-releases/department-justice-finds-pa-court-system-violated-federal-law-banning-medication

Philadelphia, PA – The U.S. Department of Justice has found that Pennsylvania’s state courts violated the Americans with Disabilities Act when its courts prohibited or limited access to medications for opioid use disorder – specifically methadone, buprenorphine, and naltrexone. The letter of findings, which was published on Wednesday, detailed discriminatory practices in a wide array of court-supervised settings in the Unified Judicial System of Pennsylvania, including drug courts, mental health courts, DUI courts, probation, and parole.

The DOJ’s investigation was initiated after a complainant represented by the Legal Action Center was forced to taper off of buprenorphine under the Jefferson County Court of Common Pleas policy prohibiting “any opiate based treatment medication.” The American Civil Liberties Union of Pennsylvania had fielded a similar complaint from another individual in Jefferson County. The two advocacy groups urged the court to rescind its policy, which it did in 2018.

The federal investigation and its subsequent findings show that several courts in Pennsylvania have engaged in similar practices, in violation of the ADA. Specifically, the DOJ determined that these policies and practices were “rooted in stereotypes and myths, rather than science,” were “not justified by any individualized medical or security assessments,” and “directly conflicted with medical guidance on (opioid use disorder) medication.”

“I feel vindicated,” said LAC’s complainant. “Where I’m from, there’s unfortunately a lot of people who have been affected by the drug epidemic, and, when the court put that order in place, it affected a lot of people. I knew that I had to stand up for what was right, and I’m super grateful that the DOJ stepped in and for everything that LAC did to help me. When I first heard this news, I got choked up because I would have been dead. Suboxone saved my life – there’s no doubt in my mind. There are so many people that need the same help and would benefit from medication for opioid use disorder. We don’t need to bury anyone else.”

“With a record 100,000 overdose deaths in the last year, it is crucial that courts facilitate, rather than hinder, access to life-saving medications for people with opioid use disorder. This letter of findings, when joined with the DOJ’s December 2021 settlement of similar claims against the Massachusetts Parole Board, shows that courts and community supervision entities around the country that engage in such discriminatory practices need to stop now, ” explains Sally Friedman, LAC’s senior vice president of legal advocacy.

“Evidence overwhelmingly shows that medication for opioid use disorder helps people avoid illicit drug use and overdose death and reduces involvement in the criminal legal system,” states Rebekah Joab, a staff attorney for LAC. “Rather than leaving treatment decision-making to individuals and their clinicians, some courts prohibit addiction medication based on their own biases and stigma. These findings put courts on notice that such practices not only violate federal anti-discrimination law, but put individuals at great risk of multiple harmful outcomes.”

“Pennsylvania recorded the fourth highest number of drug overdose deaths in the nation from May 2020 to April 2021,” said Sara Rose, deputy legal director for the ACLU of Pennsylvania. “We hope that Pennsylvania courts will work with the DOJ to ensure that people with opiate use disorder receive the treatment they need and are entitled to receive.”

The DOJ has given the Pennsylvania court administrators seven days to respond.

Will Prosecuting Medical Errors Lead to a Culture of Silence?

This is not the first time that a member of a hospital system that has been convicted for the death of a pt because of a med error. The med error was made by a technician in preparing a IV.. and the pharmacist did not catch the fact that the tech used 26.3% NACl instead of 0.9% NACl in the IV.  This was a decade ago, and back then, many states did not require technicians to be registered or certified.  Because of that the technicality … the tech had no authority by the board of pharmacy… since they only have authority over those who are registered/certified and licensed by the Board of Pharmacy.  There are several related stories and hyperlinks in the hyperlink below.  Just like the issue with the nurse and a pt death, there was a number of “system issues” that contributed to the death of the little girl in Ohio.

Pharmacist Jailed for Fatal Medication Error

https://www.pharmacyerrorinjurylawyer.com/pharmacist_jailed_for_fatal_me_1/

An Ohio pharmacist spent six months in jail for a medication error that led to the death of a two year-old child. Emily Jerry’s parents took her to a Cleveland hospital in February 2006 for the last of a series of cancer treatments. Her doctors ordered an intravenous chemotherapy solution. A pharmacy technician prepared her medication with the incorrect dosage of saline, 23 percent instead of 1 percent, and supervisor Eric Cropp signed off on the technician’s work. The saline amount proved to be lethal. Emily slipped into a coma shortly after the solution was administered, and she died several days later.

Will Prosecuting Medical Errors Lead to a Culture of Silence?

— Healthcare workers fearful of repercussions from former nurse RaDonda Vaught’s conviction

https://www.medpagetoday.com/special-reports/exclusives/97911

Healthcare workers are alarmed by the conviction of former Nashville nurse RaDonda Vaught, who now faces prison time over a medical error.

“We could all and probably have been close to this situation because we’re continuously stretched too thin,” Kelsey Fassold, RN, an ICU nurse, said in a LinkedIn post. “We try so hard to do the best by our patients while the odds are stacked against us.”

Jeremy Faust, MD, MedPage Today’s editor-in-chief, said in an Inside Medicine post that the verdict “may contribute to a culture of silence around medical errors.”

“Such silence may make systemic problems less readily identified and rectified. This is the opposite of what we need,” Faust wrote. “We need to destigmatize human errors, acknowledge them, and learn from them.”

On Friday, Vaught was convicted of negligent homicide and gross neglect of an impaired adult, after she allegedly gave 75-year-old Charlene Murphey the paralytic vecuronium when she was meant to give her the anti-anxiety drug Versed. Vaught had been acquitted of a reckless homicide charge.

Vaught faces 1 to 2 years in prison for the negligent homicide charge, and 3 to 6 years on the gross neglect charge, according to Kaiser Health News. Her sentencing is scheduled for May 13.

Typically, serious medical errors are handled by licensing boards or civil courts — not prosecutors.

The American Nurses Association said in a statement that the “criminalization of medical errors could have a chilling effect on reporting and process improvement.”

“ANA supports a full and confidential peer review process in which errors can be examined and system improvements and corrective action plans can be established,” the statement said. “Transparent, just, and timely reporting mechanisms of medical errors without the fear of criminalization preserve safe patient care environments.”

Faust said that during his career, he witnessed a very similar error. Instead of confusing vecuronium with Versed, Faust said a nurse gave the paralytic rocuronium when she was meant to give the antibiotic Rocephin.

“Fortunately, the mistake was immediately recognized, and the patient suffered no immediate or long-term consequences,” Faust wrote. “In fact, the patient was informed as to what was happening in real time, given a play-by-play narration of what had just happened and what would happen next,” which included giving Sugammadex to reverse the effects of rocuronium.

“The nurse who made the mistake was experienced, respected, and every bit as caring as the very best healthcare colleagues I have worked with over the years,” Faust wrote. “In other words, this was not some green, distracted, or emotionally detached bad apple. In my mind, all of that added up to one thing: this could have happened to anyone.”

“If honest errors lead to criminal convictions, every incentive will be to sweep things under the rug,” Faust added. “If we don’t learn from both our successes and our failures, things will get worse, not better.”

Fassold noted in her LinkedIn post that she considered Vaught’s mistake a “systemic error” and that “when something bad happened, the nurse took the heat.”

“Nurses are constantly put in unsafe and harmful conditions that can and will hurt patients. Not because they’re not trying, but because they’re working themselves to death trying to keep up with what the system demands from them,” she wrote — a sentiment that has echoed throughout the nursing world as it struggled to provide care through the COVID-19 pandemic.

“Nursing ratios are far worse now than they ever have been,” she continued. “How many more situations will occur just like this? It’s time nurses stand up for themselves, their license, and their life. It’s time nurses say no to unsafe assignments. It’s time nurses tell administration that what [they’re] demanding is unsafe and harmful. It’s time we all stand together and demand change.”

Vanderbilt University Medical Center, Vaught’s former employer when the error occurred, said via an email from a spokesperson that it did not have a comment on the verdict.

Can You Be Held Liable for Prescribing Opioids in Good Faith?

Can You Be Held Liable for Prescribing Opioids in Good Faith?

https://www.medpagetoday.com/opinion/second-opinions/97904

The Supreme Court is considering this question in Ruan v. United States

Earlier this month, the Supreme Court heard oral arguments in a case that will impact how doctors can treat patients where opioids are involved. The threshold question in Ruan v. United States, which came to the Supreme Court from the U.S. Court of Appeals for the Eleventh Circuit, is when the care a doctor provides patients crosses the line into a criminal act where the doctor is prescribing opioids.

Xiulu Ruan, MD, practiced medicine as a board‐certified pain specialist in Alabama, and was indicted in 2016 for unlawful distribution of opioids. The jury in the trial court convicted Ruan and other physicians in his practice based on a ruling that did not allow doctors to claim a defense of “good‐faith” where they honestly prescribed opioids under the belief that it was the right thing to do medically. Once the case reached the Eleventh Circuit on appeal, Ruan was essentially doomed, as that federal appellate circuit does not recognize a good-faith defense in cases such as this. He lost and appealed to the Supreme Court on a writ of certiorari, a court process to seek judicial review of a decision from a lower court.

John Brennan, JD, a New Jersey criminal defense lawyer, explains that the heart of the question presented to the Court in this case is what is and isn’t reasonable medical judgment:

“The argument of the doctors involved in the case was that the Supreme Court should look at the good faith of the doctors prescribing opioids. In a situation where a doctor genuinely believes that writing an opioid prescription falls within their normal course of practice, that this should not be viewed as a criminal act and they shouldn’t be convicted of unlawful distribution under the Controlled Substances Act.”

In the recent oral arguments, the Supreme Court Justices seemed to be leaning towards overturning the Eleventh Circuit and siding with the convicted doctors. However, the notion of reasonable belief and subjective intention are going to be difficult to agree upon because they can be a little slippery.

Three Justices — Brett Kavanaugh, Neil Gorsuch, and Chief Justice John Roberts — each expressed concerns for doctors who would be on the wrong side of a close professional judgment call, pointing out that doing so could result in decades in prison. When Justice Clarence Thomas asked whether the standards regulators set forth on this issue were insufficiently clear, counsel for Ruan replied that the elements of knowingly and intentionally misprescribing are left to states and administrative boards, as there is no clear federal guidance on this issue.

For the Justices, this will essentially come down to a question of reasonable professional practice, which can be difficult to pin down in medicine. At least from the nature and tone of the questioning at the oral argument, the Justices seem unwilling to look at the Controlled Substances Act in as restrictive a manner as the Eleventh Circuit did. While pinning down a reasonable good-faith defense is going to be a real challenge for the Court, the outcome here relies upon it, as does intelligent and balanced enforcement of the Controlled Substances Act.

The importance of this case and the underlying issue — the opioid crisis — cannot be overstated. A recent position paper by the American Medical Association made it clear that the nation’s opioid and drug overdose epidemic continues to worsen with metrics far beyond earlier projections. The ruling in this case could impact its trajectory.

While both the Alabama Federal Court jury and the Eleventh Circuit convicted Ruan for violating provisions of the Controlled Substances Act, among other laws, the larger question goes far beyond the wrongdoing of any doctor who may have been motivated to prescribe opioids for financial gain.

Simply put, a doctor’s ability to practice medicine properly would be limited by an inability to make judgment calls. If doctors fear huge penalties for honest mistakes, they will err on the side of not treating. So, if the Court’s ruling sets forth an overly restrictive policy aimed at the small number of physicians motivated by their own self-interest, it may be patients in pain who suffer in the long run.

Will the Supreme Court overturn the Eleventh Circuit here? In my opinion, they absolutely need to. While ensuring the availability of opioids may seem counterintuitive in a national opioid crisis, this is neither the legal nor medical issue presented in this case. Having the Controlled Substances Act without a good‐faith defense makes no sense from a legal or practical perspective. If the Supreme Court doesn’t overturn the Eleventh Circuit, they are essentially saying the binary between good doctors and those who run illegal pill mills is always crystal clear.

We can still be against pill mill doctors but agree that, in all jurisdictions, doctors need the legal ability to follow their best medical judgment to prescribe or not to prescribe as they see fit. If doctors are overly fearful of the legal consequences of perceived misprescribing — which may be the result of the current ruling in the Eleventh Circuit — patients in chronic pain will suffer unnecessarily. Beyond being fundamentally unfair, it is also a specious medical argument for any court to hold that physicians should still be convicted for unlawful distribution of controlled substances if they sincerely believe they were prescribing the drugs under acceptable standards of practice.

FDA authorizes 2nd booster shot for Americans over 50

FDA authorizes 2nd booster shot for Americans over 50

https://abc7.com/covid-booster-2nd-for-seniors-fda/11689371/

WASHINGTON — U.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds.

The Food and Drug Administration’s decision opens a fourth dose of the Pfizer or Moderna vaccines to that age group at least four months after their previous booster.

Until now, the FDA had cleared fourth doses only for people 12 and older who have severely weakened immune systems. The agency said this especially fragile group also can get an additional booster, a fifth shot.

The latest expansion, regardless of people’s health, allows an extra shot to millions more Americans – and the question is whether everyone who’s eligible should rush out and get it. The Centers for Disease Control and Prevention is expected to weigh in.

Everyone eligible for a first booster who hasn’t gotten one yet needs to, FDA vaccine chief Dr. Peter Marks said. But the second booster is only for these higher-risk groups because “current evidence suggests some waning of protection” for them.

The move comes at a time of great uncertainty. COVID-19 cases have dropped to low levels after the winter surge of the super-contagious omicron variant. Two vaccine doses plus a booster still provide strong protection against severe disease and death, CDC data show.

But an omicron sibling is causing a worrisome jump in infections in Europe — and spreading in the U.S. – even as vaccination has stalled. About two-thirds of Americans are fully vaccinated, and half of those eligible for a first booster haven’t gotten one.

Pfizer had asked the FDA to clear a fourth shot for people 65 and older, while Moderna requested another dose for all adults “to provide flexibility” for the government to decide who really needs one. The FDA set age 50 as the threshold for both companies. As for the immune-compromised, only the Pfizer vaccine can be used in those as young as 12; Moderna’s is for adults.

There’s limited evidence to tell how much benefit another booster could offer right now. FDA made the decision without input from its independent panel of experts that has wrestled with how much data is required to expand shots.

“There might be a reason to top off the tanks a little bit” for older people and those with other health conditions, said University of Pennsylvania immunologist E. John Wherry, who wasn’t involved in the government’s decision.

But while he encourages older friends and relatives to follow the advice, the 50-year-old Wherry – who is healthy, vaccinated and boosted – doesn’t plan on getting a fourth shot right away. With protection against severe illness still strong, “I’m going to wait until it seems like there’s a need.”

None of the COVID-19 vaccines are as strong against the omicron mutant as they were against earlier versions of the virus. Also, protection against milder infections naturally wanes over time. But the immune system builds multiple layers of defense and the type that prevents severe illness and death is holding up.

During the U.S. omicron wave, two doses were nearly 80% effective against needing a ventilator or death – and a booster pushed that protection to 94%, the CDC recently reported. Vaccine effectiveness was lowest – 74% – in immune-compromised people, the vast majority of whom hadn’t gotten a third dose.

U.S. health officials also looked to Israel, which during the omicron surge opened a fourth dose to people 60 and older at least four months after their last shot. The FDA said no new safety concerns emerged in a review of 700,000 fourth doses administered.

Preliminary data posted online last week suggested some benefit: Israeli researchers counted 92 deaths among more than 328,000 people who got the extra shot, compared to 232 deaths among 234,000 people who skipped the fourth dose.

What’s far from clear is how long any extra benefit from another booster would last, and thus when to get it.

“The ‘when’ is a really difficult part. Ideally we would time booster doses right before surges but we don’t always know when that’s going to be,” said Dr. William Moss, a vaccine expert at the Johns Hopkins Bloomberg School of Public Health.

Plus, a longer interval between shots helps the immune system mount a stronger, more cross-reactive defense.

“If you get a booster too close together, it’s not doing any harm – you’re just not going to get much benefit from it,” said Wherry.

The newest booster expansion may not be the last: Next week, the government will hold a public meeting to debate if everyone eventually needs a fourth dose, possibly in the fall, of the original vaccine or an updated shot.

As for updating vaccines, studies in people – of omicron-targeted shots alone or in combination with the original vaccine – are underway. The National Institutes of Health recently tested monkeys and found “no significant advantage” to using a booster that targets just omicron.

why don’t law firms “take on” the DEA ?

It is pretty simple answer…  Law firms … like all other businesses is a FOR PROFIT BUSINESS. Just look at all the “ambulance chasing “ personal injury law firms that advertise on TV…   Most claim… you don’t pay … unless YOU WIN… They don’t take every case that someone comes to them with…. they weigh their chances of winning or losing… basically there is a handful of well worn paths to a pot of money – mostly from insurance companies.  What they don’t regularly share is that most settlements are done by exchanging letters – or mediation – between the insurance company the law firm until a $$$ sum is agreed upon… very few go to court.

With law firms that take a case on contingency basic… I would expect those that are settled with negotiating by letter that the law firm will probably get rewarded at least ten times what the exchange of negotiation  costs them.

If someone is bold enough to try and sue the DEA.. they are not going to get any $$$ from the FEDS… if one wins… ideally the win will mean that they change their policies and hope that they don’t find a work around for what they were sued for and start doing a similar thing again. I suspect that most law firms would take on a case that person wants to sue over… if they can come up with enough cash to cover all the anticipated hours they will bill for… in trying to suing the Fed government…  that could involve several million

I know a person that was an employee of and sued a large corporation over violations of  EEOC, ADA, and whistler blower. The law firm that  took the case on a contingency basis and the case was settled via mediation – never went to trial –  my understanding is that the law firm tracked the number of billable hours for this case and at the rate they charge.. the total was NORTH of ONE MILLION…   I don’t know what the final settlement was, but it is my understanding is that the attorney that was the “lead” on this case… was MADE A PARTNER of the firm after this case was settled.  One can only imagine what the total settlement was, to make the lead attorney a partner in the firm… meaning that this attorney will share in the profits of the law firm going forward on top of what the attorney is paid for their billable hours.

 

Cannabis Linked to Less Opioid Use in Back Pain, Osteoarthritis

Cannabis Linked to Less Opioid Use in Back Pain, Osteoarthritis

Usage fell by almost 40% in 6 months, although it’s not clear if medical pot was the reason

https://www.medpagetoday.com/meetingcoverage/aaos/97887

Medical cannabis can greatly reduce or eliminate the need for opioid painkillers in patients with chronic back pain and osteoarthritis, a pair of studies found.

The studies, reported at the annual meeting of the American Academy of Orthopaedic Surgeons annual meeting and published in Cureus, are limited since they don’t include control groups and can’t offer insight into whether patients would have weaned themselves off opioids in any case without using cannabis. However, a co-author of both studies, Ari Greis, DO, of Rothman Orthopedic Institute at Thomas Jefferson University in Philadelphia, told MedPage Today that the findings suggest that “cannabinoids are a viable alternative to opioids to treat chronic pain.”

“We need to make a shift in the way we approach chronic pain and really limit the use of opioids to people with acute pain and post-surgical pain,” he added, explaining that cannabis works as an alternative over the long term because it has low rates of side effects and addiction. And, he said, unlike opioids, cannabis doesn’t kill patients.

The studies found that nearly 39% of chronic back pain sufferers stopped using opioids after 6 months, as did 37.5% of those with osteoarthritis.

For the chronic back pain study, researchers from 2018 to 2019 recruited 186 patients with spine disorders who took opioids (46.8% male, average age 64) and hadn’t undergone recent surgery. Of these, 135 used an average of less than 15 morphine milligram equivalents (MME)/day of opioids, while the remaining 52 patients used more.

The participants used medical cannabis, which is allowed in Pennsylvania, and were monitored for 9 months after enrollment.

From 6 months before cannabis use to 6 months after, the average MME/day dropped from 15.1 to 11.0 (-27%, P<0.01), and 38% of patients stopped using opioids entirely, the researchers reported. Pain scores also dropped.

Investigators sent questionnaires about pain and disability to the participants 3, 6, and 9 months after medical cannabis certification.

Among the 144 respondents, 47% reported using a single route of administration. The most common forms among all patients were vaporized oil and sublingual tincture (both 41.7%) and topical (34.7%), oral (29.9%) and vaporized flower (21.5%). Of 71 patients surveyed, 56.3% said they didn’t feel intoxicated or high, while 43.7% said they did. Of the latter group, most said the treatment didn’t interfere with their daily activities.

For the osteoarthritis study conducted during the same time period, the investigators recruited 40 patients (77.5% women, average age of 67.9) — 18 with primary knee pain and 12 with primary shoulder pain. The average MME/day dropped from 18.2 to 9.8 (-46.3%, P<0.05) from 6 months prior to cannabis use to 6 months after. The percentage of patients in the study who stopped using opioids entirely was 37.5%. Pain scores also fell.

About two-thirds of patients administered the drug via sublingual tincture, followed by a third who used a topical route, 21% who used vaporized oil and 9% who used vaporized flower. Of these, 57.1% of 21 respondents said they didn’t feel intoxicated/high. Of the nine who said they did feel intoxicated/high, three said it didn’t interfere with their daily activities.

“A lot of patients got symptom relief without intoxication or found that the mild intoxication either didn’t interfere with their activities of daily living or was pleasurable to some degree,” Greis said.

He added that research suggests that cannabis works on pain by making people more relaxed “and maybe noticing other pleasurable feelings in the body so they’re not as focused on the pain. It changes their perception of the pain or their attitude towards the pain.”

Geoffrey S. Marecek, MD, of Cedars-Sinai in Los Angeles, who was not involved with either study, said the findings appear valid, although larger numbers would make them more generalizable.

The results add to a large body of evidence that medical cannabis is helpful for chronic pain, he told MedPage Today, Exhale Wellness has CBD quality products. However, “we are starting to accumulate data that medical cannabis does not do much for acute pain – for example, after a fracture or surgery, though I think the jury is still out.”

“We also don’t know much about potential side effects in patients who are recovering from orthopedic surgery or other procedures where a healing response — e.g., of a fracture — is required,” Marecek added.

Study limitations include that the team didn’t have detailed information about the cannabis products used by the patients or the doses of tetrahydrocannabinol (THC, which makes people high) and cannabidiol (CBD, which makes people relaxed).

However, Greis said, “in my experience, patients who are truly looking for some symptom relief – and not get intoxicated — generally follow the guidelines that I give them: Start with lower dosages of THC, usually combined with CBD. I generally recommend oral routes of delivery or topical cannabinoids as opposed to inhalable methods like vaporization, [which] could be irritating to patient’s lungs,” he added.

Neither study examined the cost of cannabis, and medical marijuana remains illegal in several states.

This is what no pain management looks like in the state of Washington

This is what no pain management looks like in the state of Washington

call their bluff with a letter from attorney ?

 

I am hearing from more and more pain pts whose pain is under managed or not managed at all.  Because many large healthcare corporations have adopted a “no opiate pain management policy”

Anything above 135/85 is considered “high” and most healthcare professionals will consider BP above 200/100 being in stroke/heart attack territory.

The hyperlink above is a fairly long post that I created some time ago…  that gives some suggestions as to a pt’s option in dealing with such issues.

These large healthcare corporations, hospitals, chain pharmacies, insurance/pbm are behaving much like the criminals that we see in some of our large cities.  You know the ones who are going into retail stores and cleaning the shelves off and walk/run out the door without paying…  Some district attorneys, in some of these large cities won’t even prosecute a person unless they steal > $950.00… and some of these cities have a “no bail” policy… so the criminals are back out on the street in a matter of hours…

Mostly likely, they go right back to stealing more merchandise from another store … because they know that they will have no consequences to deal with.  Apparently these large healthcare corporations are functioning under a similar mindset.  If they provide no controlled substances to pts…. they have no worry about the DEA coming and screwing with them and fining them for exceeding some -undefined – standard of care and best practices.

To date, none of these healthcare corporations have suffered any financial consequences for establishing corporate  no opiate – policies that stop their employees from prescribing controlled meds to any pts. 

I would suspect that until those healthcare corporations has to deal with consequences from their “no-opiate policies” things will not change or even more of those corporations will join them with implementing no-opiate policies.

Unless some law firm gets involved and/or pts get some lawsuit started… IMO … the community’s future may closely look like what can be seen in the rear view mirror today.